Speciality: Oncology
Description:
A warm welcome to all the medical professionals in this interesting learning session on first line management of ALK positive lung cancer.
In this webinar, a panel discussion would take place involving Dr. Jessicca Lin as the primary speaker and Dr. T. Raja, Dr. Amit Rauthan, Dr. B. K. Smruti and many other panelists who will share the important facts associated with first line management of ALK positive lung cancer.
Starting with the case scenario of non-small cell lung cancer, Dr Jessica has explained all details associated with the incidence, progression and treatment of ALK positive lung cancer. Further, the panel discussion will give more knowledge.
ALK-positive lung cancer represents about 4% of lung cancer which generally appears in adenocarcinoma non-small cell lung cancer. Patients with ALK-positive are mostly younger than the average lung cancer patient and also do not have a smoking history compared to other lung cancers.
Therefore, you are going to have an overall knowledge regarding management of ALK positive lung cancer. Listen to the webinar, grab the knowledge that is shared and follow HiDoc for more such interesting webinar sessions.
See More Webinars @ Hidoc Webinars
1.
No increased risk of childhood cancer near UK nuclear sites, study finds
2.
The Cherenkov color image shows the possibility of improving the quality of radiation therapy.
3.
Hematocrit Stabilized in Polycythemia Vera Under Novel Hepcidin Mimetic Treatment.
4.
According to JAMA, even four minutes a day of exercise can lower the risk of cancer.
5.
The risk of lung cancer recurrence is linked to hypoxemia brought on by sleep apnea.
1.
Unlocking the Potential of Cancer Antigen 19-9 for Early Detection
2.
The Future of Cancer Care: Genetics, Support Systems, and Emerging Therapies
3.
Case Study: Artificial Intelligence in Early Cancer Detection
4.
A Closer Look at MCV Modules: Features, Functions, and Benefits
5.
Oncological Surgery Today: Personalized, Interdisciplinary Approaches to Cancer Care
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Thromboprophylaxis In Medical Settings
2.
Understanding the causes of anemia in adults beyond nutritional deficiencies
3.
Breaking Down PALOMA-2: How CDK4/6 Inhibitors Redefined Treatment for HR+/HER2- Metastatic Breast Cancer
4.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part II
5.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part V
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation